Author

Xiang Chi

Institution: Oklahoma State University

Observed institution: Oklahoma State University

ORCID: 0009-0003-4853-7931

Observed ORCID: 0009-0003-4853-7931

OpenAlex ID: A5102969901

Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model

2024 · Bin Tan, Xiaoming Zhang, et al. · Science · 140

Design of quinoline SARS-CoV-2 papain-like protease inhibitors as oral antiviral drug candidates

2025 · Prakash Jadhav, Xueying Liang, et al. · Nature Communications · 37

SARS-CoV-2 Nsp15 endoribonuclease subverts host defenses to enhance viral fitness in lung cells

2025 · Xiang Chi, Xueying Liang, et al. · Journal of Virology · 8

Structure-Based Design of Covalent SARS-CoV-2 Main Protease Inhibitors Targeting the Nirmatrelvir-Resistant E166 Mutants

2026 · Zhengjun Cai, Navita Kohaal, et al. · JACS Au · 5

Characterization of the Cross-Resistance of SARS-CoV-2 Main Protease Inhibitors, Ibuzatrelvir, Ensitrelvir, and Nirmatrelvir

2026 · Haozhou Tan, Xiang Chi, et al. · ACS Pharmacology & Translational Science · 4

Single-Cell RNA-Seq Identifies Immune Remodeling in Lungs of β-Carotene Oxygenase 2 Knockout Mice with Improved Antiviral Response

2025 · Yashu Tang, William Lin, et al. · Nutrients · 2

Coronavirus Nsp15 endoribonuclease: linking viral RNA regulation to immune evasion and viral fitness

2026 · Xueying Liang, Xiang Chi, et al. · Journal of Virology · 1

Structure-guided design of SARS-CoV-2 PLpro inhibitors with in vivo antiviral efficacy

2025 · Ahmadullah Ansari, Francesc Ruiz, et al. · Structural Dynamics

Feline Coronaviruses

2025 · Xiang Chi, Xufang Deng · Springer eBooks

Works count: 9

Citation count: 197

H-index: 4

I10-index: 2